AC
NVNO

Armistice Capital’s enVVeno Medical NVNO Stock Holding History

Armistice Capital’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,457
Closed -$2.24M – 388
2023
Q4 		$2.24M Buy
+12,457
New +$1.98M 0.03% 153

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Armistice Capital's NVNO Position: Q1 2024 in Review

Armistice Capital sold out of enVVeno Medical (NVNO) in Q1 2024, closing a stake of 12,457 shares — an estimated $2.24M sold.

Armistice Capital first reported a position in NVNO in Q4 2023 and held it in 1 quarter. The position peaked at $2.24M in Q4 2023. 31 funds tracked by Wall St. Rank hold NVNO as of Q1 2024.

  • Armistice Capital reported no remaining enVVeno Medical position as of Q1 2024 after selling out during the quarter.
  • Armistice Capital sold 12,457 enVVeno Medical shares in Q1 2024, an estimated $2.24M.
  • Armistice Capital first reported a position in enVVeno Medical in Q4 2023 and held it in 1 quarter.
  • Armistice Capital's enVVeno Medical position peaked at $2.24M in Q4 2023.
  • 31 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2024.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.